Highlights from the GMP market and Valicare
You want to know what is driving the industry and ourselves? We have compiled the recent news for you here.
32 Results found
07/25/2022
Celebrating 20 years of Valicare
From drug development to marketing authorization, Valicare supports chemical, pharmaceuticals and biotechnology companies around the globe.
06/25/2022
New ICH Q14 Guideline: Analytical procedure development
Analytical procedure development: harmonization, development process as well as improvement of change management, approval and communication with ...
02/18/2022
Revision of ICH Q9 (R1) Guideline on Quality Risk Management
Innovations in the implementation of risk management in the pharmaceutical industry: product availability, hazard identification, and attention to ...
05/27/2021
Novelties by EMA on medicinal products with genetically modified cells
Updated EMA guideline for medicinal products containing genetically modified cells provides innovations, recommendations and improvements to be ...
04/15/2021
Toxicological assessment gain acceptance for cleaning validation
WHO publishes decision on setting acceptance criteria for cleaning validation
02/10/2021
FDA approves Breyanzi®, a new CAR-T cell therapy drug
Fourth approved CAR-T cell therapy soon to be available in Europe?
02/04/2021
Vaccinations with mRNA-based medicinal products
How do mRNA-based medicinal products work and how safe are they?
01/08/2021
Integrated Qualification and Validation Guide
New ECA guide helps saving time and money by customer-supplier partnership on qualification and validation.
10/26/2020
Nitrosamines in active substances and finished medicinal products
EMA strongly requests the risk-based proof that active substances and finished medicinal products are free of nitrosamines. Are you prepared for this?
10/23/2020
Valicare Extends GxP Expertise
New Consulting Services for the Transition from Development to Clinical Manufacturing
09/24/2020
MSC & Covid-19
In order to identify approaches to manage the current Covid-19 pandemic, the therapeutic use of mesenchymal stromal cells (MSCs) is increasingly ...
2/
3